[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

CZ20033519A3 - Dibenzocycloheptene compound - Google Patents

Dibenzocycloheptene compound Download PDF

Info

Publication number
CZ20033519A3
CZ20033519A3 CZ20033519A CZ20033519A CZ20033519A3 CZ 20033519 A3 CZ20033519 A3 CZ 20033519A3 CZ 20033519 A CZ20033519 A CZ 20033519A CZ 20033519 A CZ20033519 A CZ 20033519A CZ 20033519 A3 CZ20033519 A3 CZ 20033519A3
Authority
CZ
Czechia
Prior art keywords
group
cooh
dif
chloro
formula
Prior art date
Application number
CZ20033519A
Other languages
Czech (cs)
English (en)
Inventor
Yoshiaki Kuroki
Hitoshi Ueno
Tetsushi Katsube
Tetsuo Kawaguchi
Eiji Okanari
Ichiro Tanaka
Masayuki Tanaka
Masahiko Hagihara
Original Assignee
Ube Industries, Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ube Industries, Ltd. filed Critical Ube Industries, Ltd.
Publication of CZ20033519A3 publication Critical patent/CZ20033519A3/cs

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/18—Halogen atoms or nitro radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/12—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CZ20033519A 2001-06-27 2002-06-27 Dibenzocycloheptene compound CZ20033519A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2001193859 2001-06-27

Publications (1)

Publication Number Publication Date
CZ20033519A3 true CZ20033519A3 (en) 2004-06-16

Family

ID=19032065

Family Applications (1)

Application Number Title Priority Date Filing Date
CZ20033519A CZ20033519A3 (en) 2001-06-27 2002-06-27 Dibenzocycloheptene compound

Country Status (9)

Country Link
US (1) US7309718B2 (zh)
EP (1) EP1408033A4 (zh)
JP (1) JPWO2003002539A1 (zh)
KR (1) KR20040030700A (zh)
CN (1) CN1240684C (zh)
CA (1) CA2452105A1 (zh)
CZ (1) CZ20033519A3 (zh)
HU (1) HUP0400322A2 (zh)
WO (1) WO2003002539A1 (zh)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2006151809A (ja) * 2002-12-26 2006-06-15 Ube Ind Ltd ベンゾシクロヘプタピリジン化合物
CA2551037A1 (en) 2003-09-22 2005-03-31 Banyu Pharmaceutical Co., Ltd. Novel piperidine derivative
KR100700440B1 (ko) * 2005-01-14 2007-03-27 네오뷰코오롱 주식회사 청색 발광 유기 화합물 및 이를 포함하는 유기 발광다이오드
DE102005022020A1 (de) * 2005-05-12 2006-11-23 Merckle Gmbh Dibenzocycloheptanverbindungen und pharmazeutische Mittel, welche diese Verbindungen enthalten
EP1916239A4 (en) 2005-08-10 2009-10-21 Banyu Pharma Co Ltd PYRIDONE COMPOUND
CA2624656A1 (en) * 2005-10-21 2007-05-03 Merck & Co., Inc. Tyrosine kinase inhibitors
KR101038727B1 (ko) * 2008-06-02 2011-06-03 차창호 라틴 문자 입력 장치 및 이를 이용한 휴대용 단말기
CN101786942B (zh) * 2009-01-23 2014-01-08 常州亚邦制药有限公司 2,4-二氯-10,11-二氢-5H-二苯并[a,d]环庚烯-5-醇的制备方法
CN101531570B (zh) * 2009-04-17 2012-10-10 中国科学院上海有机化学研究所 1，2-取代-5-乙炔基-(或10，11-二氢)-5H-二苯基[a，d]环庚烯(烷)-5-醇、合成方法及用途
CN103193599A (zh) * 2012-01-06 2013-07-10 中国科学院上海有机化学研究所 多官能团取代-5-乙炔基-10,11- 二氢-5H-二苯基[a,d]环庚烷-5-醇的合成方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4235820A (en) * 1976-08-10 1980-11-25 Merck & Co., Inc. Process for dibenzocycloheptene compounds
US5221678A (en) * 1990-07-26 1993-06-22 Merck Frosst Canada, Inc. (quinolin-2-ylmethoxy)tetrahydrocarbazoles as inhibitors of the biosynthesis of leukotrienes
US5591752A (en) * 1993-02-16 1997-01-07 Ube Industries, Ltd. Quinoline derivative
US6248781B1 (en) * 1998-10-21 2001-06-19 Novo Nordisk A/S Compounds useful in the treatment of conditions mediated by peroxisome proliferator-activated receptors (PPAR)
US20030216571A1 (en) * 1999-12-28 2003-11-20 Yoshiaki Kuroki Tricyclic compounds

Also Published As

Publication number Publication date
US20040180884A1 (en) 2004-09-16
WO2003002539A1 (fr) 2003-01-09
EP1408033A4 (en) 2004-11-24
HUP0400322A2 (hu) 2004-12-28
CN1531528A (zh) 2004-09-22
EP1408033A1 (en) 2004-04-14
KR20040030700A (ko) 2004-04-09
CA2452105A1 (en) 2003-01-09
US7309718B2 (en) 2007-12-18
JPWO2003002539A1 (ja) 2004-10-14
CN1240684C (zh) 2006-02-08

Similar Documents

Publication Publication Date Title
US9085575B2 (en) Tri- and tetracyclic pyrazolo[3,4-B]pyridine compounds as antineoplastic agent
US5236937A (en) Pyridinyl compounds which are useful as angiotensin ii antagonists
US6011033A (en) Phenylene derivatives
TW201022283A (en) Fused imidazole carboxamides as TRPV3 modulators
JPH05230055A (ja) 三環式ヘテロ環化合物、その製法及びこれを含有する抗−痛覚過敏作用を有する医薬組成物
EP1560834B1 (en) New tricyclic derivatives as ltd4 antagonists
JPH05506455A (ja) ロイコトリエンｄ↓４拮抗剤としてのキノリニル―ベンゾヘテロ二環式誘導体
CZ20033519A3 (en) Dibenzocycloheptene compound
JPH0774204B2 (ja) 化合物
JPS634537B2 (zh)
WO2009060209A1 (en) 6,6-fused bicyclic aromatic compounds and their therapeuti use
PL160574B1 (pl) Sposób wytwarzania nowych pochodnych aminoalkoksyfenylu PL PL
US20100120839A1 (en) Pyrazoles useful in the treatment of inflammation
WO2007004688A1 (ja) キサンチンオキシダーゼ阻害剤
JP2006151809A (ja) ベンゾシクロヘプタピリジン化合物
US20030216571A1 (en) Tricyclic compounds
JP4294469B2 (ja) Ｐｄｅｉｖ阻害剤
WO2020255156A1 (en) Heterocyclic compounds as lipoxygenase inhibitors
NZ539954A (en) New tricyclic derivatives as LTD4 antagonists
JPH09323975A (ja) フェニレン誘導体
JPH10114753A (ja) 縮環ピリダジニルグアニジン誘導体、その製法及び剤
JPH0633255B2 (ja) テトラヒドロキノリン誘導体